Edgewell Personal Care Company (EPC) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of October 3, 2026. The Consumer Defensive name (Household & Personal Products) last closed at $26.97. The rating moved from Neutral to Oversold on September 30, 2026.

• Public ratingOversold (as of October 3, 2026)
• Last close$26.97
• Last changeMoved from Neutral to Oversold on September 30, 2026
• SectorConsumer Defensive
• IndustryHousehold & Personal Products

See all oversold Consumer Defensive stocks →

AI analysis

Edgewell Personal Care Company (EPC) combines a stable, defensive brand portfolio with modest free cash flow generation and a capital-allocation focus on dividends, buybacks and selective M&A. Recent market tone favors defensive names, supporting revenue stability, but structural challenges remain: competitive pressure from large incumbents and agile DTC brands, exposure to input-cost and supply-chain dynamics, and rising regulatory scrutiny in consumer-health labeling. Near-term upside is limited absent a clear improvement in margins, successful new-product traction or concrete cost-out acceleration. Balance-sheet flexibility and steady cash generation provide downside protection, while execution on e-commerce and product innovation will determine medium-term growth pathways.

Key factors

• Established, diversified personal-care brand portfolio with steady recurring demand (schick/razors, sun care, skincare).
• Defensive consumer-staples characteristics that can attract flows in risk-off environments, supporting near-term revenue stability.
• Margin pressure from input costs and competitive pricing, partially offset by ongoing cost-savings and SG&A optimization programs.
• Moderate balance-sheet flexibility and free cash flow generation, enabling buybacks, dividend support and potential small M&A.
• Industry-level noise from regulatory scrutiny of consumer-health and labeling claims increases compliance and reputational focus.
• Limited near-term growth catalysts; growth tied to product innovation, DTC expansion and international execution.

Risks

• Sustained margin compression from higher commodity, packaging or logistics costs and aggressive competitor pricing.
• Heightened regulatory enforcement or labeling/safety actions that could require corrective advertising, recalls or increased compliance costs.
• Market-share erosion to larger incumbents (P&G) and fast-growing direct-to-consumer brands that undercut pricing or win channel share.
• Macroeconomic slowdown or discretionary spending pullback that hits higher-margin or premium personal-care categories.
• Execution risk on innovation and e-commerce initiatives; slower adoption would limit growth trajectory.
• Currency volatility and interest-rate-driven cost of capital if refinancing needs arise.

Latest MarketMoodz coverage

• Mammoth Brands Eyes IPO as Deal-Driven Growth Scales2026-06-07

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.